A similar correlation was found in a recent report on metastatic colorectal cancer demonstrating a clear survival advantage for patients with an intact p53/BAX pathway (p53 wild type/BAX high) as well (Sturm et al, 1999). The gene discussed is BAX; the disease is metastatic colorectal cancer.